Antidepressant drugs in oral fluid using liquid chromatography-tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 34, Issue 2, 2010, Pages 64-72

  Coulter, Cynthia ^a   Taruc, Margaux ^a   Tuyay, James ^a   Moore, Christine ^a  

^a Immunalysis Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CLOMIPRAMINE; CYCLOBENZAPRINE; DOSULEPIN; DOXEPIN; FLUOXETINE; IMIPRAMINE; METHANOL; PROTRIPTYLINE; SERTRALINE; TRIMIPRAMINE;

ARTICLE; ELECTROSPRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID INTAKE; LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; CHEMISTRY; CROSS REACTION; DRUG STABILITY; HUMAN; IMMUNOLOGY; LABORATORY DIAGNOSIS; PROCEDURES; REPRODUCIBILITY; SALIVA;

ANTIDEPRESSIVE AGENTS; CHROMATOGRAPHY, LIQUID; CROSS REACTIONS; DRUG STABILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; REPRODUCIBILITY OF RESULTS; SALIVA; SOLID PHASE EXTRACTION; SPECIMEN HANDLING; TANDEM MASS SPECTROMETRY;

EID: 77749321371     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/34.2.64     Document Type: Article

References (23)

1. A. Brunnauer and G. Laux. Antidepressants and driving ability. Psychiatr. Prax. 30(Suppl 2): S102-105 (2003) (in German).
2. A. Brunnauer, G. Laux, E. Geiger, M. Sovka, and H.J. Moller. Antidepressants and driving ability: results from a clinical study. J. Clin. Psychiatr. 67(11): 1776-1781 (2006).
3. M.Wingen, J.G. Ramaekers, and J.A. Schmitt. Driving impairment in depressed patients receiving long-term antidepressant treatment. Psychopharmacol. 188(1): 84-91 (2006).
4. M.F. Hilton, Z. Staddon, J. Sheridan, and H.A.Whiteford. The impact of mental health symptoms on heavy goods vehicle drivers' performance. Accid. Anal. Prev. 41(3): 453-461 (2009).
5. T.P. Rohrig and L.J. Goodson. A sertraline-intoxicated driver. J. Anal. Toxicol. 28(8): 689-691 (2004).
6. J. Shen, H.J. Moller, X.Wang, S.A. Chung, G.K. Shapiro, X. Li, and C.M. Shapiro. Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients. J. Clin. Psychiatr. 70(3): 370-377 (2009).
7. K. Iwamoto, M. Takahashi,Y. Nakamura, R. Ishihara,Y. Uchiyama, K. Ebe, A. Nosa, Y. Nosa, K. Yoshida, T. Iidaka, and N. Ozaki. The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial. Hum. Psychopharmacol. 23(5): 399-407 (2008).
8. K. Iwamoto, Y. Kawamura, M. Takahashi, Y. Uchiyama, K. Ebe, K. Yoshida, T. Iidaka, Y. Noda, and N. Ozaki. Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers. Psychiatr. Clin. Neurosci. 62(5): 610-616 (2008).
9. 9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the Ora-Sure oral specimen collection device. J. Anal. Toxicol. 30(4): 274-277 (2006).
10. B.N. Patel, N. Sharma, M. Sanyal, and P.S. Shrivastav. Liquid chromatography tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma and its application to a bioequivalence study. J. Pharm. Biomed. Anal. 47(3): 603-611 (2008).
11. B.N. Patel, N. Sharma, M. Sanyal, and P.S. Shrivastav. Analysis of second-generation antidepressant drug, sertraline and its active metabolite, N-desmethyl sertraline in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(3): 221-229 (2009).
12. M. Concheiro, A. De Castro, O. Quintela, A, Cruz, and M. Lopez-Rivadulla. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal. Biochem. Chem. 391(6): 2329-2338 (2008).
13. A. De Castro, M. Concheiro, O. Quintela, A. Cruz, and M. López-Rivadulla. LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices. J. Pharm. Biomed. Anal. 48(1): 183-193 (2008).
14. B.K. Matuszewski, M.L. Constanzer, and C.M. Chavez-Eng. Strategies for the assessment of matrix effect in quantitative bioamalytical methods based on HPLC-MS/MS. Anal. Chem. 75: 3019-3030 (2003).
15. E. Chambers, D.M. Wagrowski-Diehl, Z. Lu, and J.R.Mazzeo. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B 852: 22-34 (2007).
16. A. Van Eeckhaut, K. Lanckmans, S. Sarre, I. Smolders, and Y. Michotte. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J. Chromatogr. B 877(23): 2198-2207 (2009).
17. F.T. Peters, O.H. Drummer, and F. Musshoff. Validation of new methods. Forensic Sci. Int. 165: 216-224 (2007).
18. N.M. Van Hoey. Effect of cyclobenzaprine on tricyclic antide pressant assays. Ann. Pharmacother. 39(7-8): 1314-1317 (2005).
19. E.M. Caravati, J.M. Juenke, B.I. Crouch, and K.T. Anderson. Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays. Ann. Pharmacother. 39(9): 1446-1449 (2005).
20. M. Groschl, H. Kohler, H.G. Topf, T. Rupprecht, and M. Rauh. Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugs. J. Pharm. Biomed. Anal. 47: 478-486 (2008).
21. O. Quintela, D.J. Crouch, and D.M. Andrenyak. Recovery of drugs of abuse from the Immunalysis Quantisal™ oral fluid collection device. J. Anal. Toxicol. 30(8): 614-616 (2006).
22. C. Moore, S. Rana, and C. Coulter. Determination of meperidine, tramadol and oxycodone in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. J. Chromatogr. B Biomed. Appl. 850: 370-375 (2007).
23. C. Moore, C. Coulter, K. Crompton, and M. Zumwalt. Determination of benzodiazepines in oral fluid using LC-MS-MS. J. Anal. Toxicol. 31(9): 596-600 (2007).